NORTHERN TRUST CORP - CIDARA THERAPEUTICS INC ownership

CIDARA THERAPEUTICS INC's ticker is CDTX and the CUSIP is 171757107. A total of 57 filers reported holding CIDARA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 4.58 and the average weighting 0.1%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of CIDARA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$120,569
-16.6%
127,9650.0%0.00%
Q2 2023$144,600
+1.7%
127,965
+14.3%
0.00%
Q1 2023$142,165
+78.2%
111,941
+6.1%
0.00%
Q4 2022$79,782
+20.9%
105,4900.0%0.00%
Q3 2022$66,000
+37.5%
105,490
+7.2%
0.00%
Q2 2022$48,000
-41.5%
98,3930.0%0.00%
Q1 2022$82,000
-41.4%
98,393
-11.0%
0.00%
Q4 2021$140,000
-10.3%
110,497
+58.5%
0.00%
Q3 2021$156,000
+6.8%
69,722
-3.7%
0.00%
Q2 2021$146,000
-85.3%
72,428
-80.7%
0.00%
Q1 2021$996,000
+27.7%
374,406
-4.0%
0.00%
Q4 2020$780,000
-28.9%
390,018
+1.3%
0.00%
Q3 2020$1,097,000
+151.6%
384,937
+226.2%
0.00%
Q2 2020$436,000
+263.3%
118,014
+143.7%
0.00%
Q1 2020$120,000
+7.1%
48,423
+65.6%
0.00%
Q4 2019$112,000
+124.0%
29,236
+16.4%
0.00%
Q3 2019$50,000
+13.6%
25,107
-3.6%
0.00%
Q2 2019$44,000
-44.3%
26,049
-12.1%
0.00%
Q1 2019$79,000
-22.5%
29,624
-31.7%
0.00%
Q4 2018$102,000
-46.3%
43,380
+0.6%
0.00%
Q3 2018$190,000
-2.6%
43,121
+15.3%
0.00%
Q2 2018$195,000
+37.3%
37,386
+5.1%
0.00%
Q1 2018$142,000
+19.3%
35,581
+102.5%
0.00%
Q4 2017$119,000
-19.0%
17,567
-3.2%
0.00%
Q3 2017$147,000
+7.3%
18,140
-0.1%
0.00%
Q2 2017$137,000
-84.4%
18,156
-83.9%
0.00%
Q1 2017$878,000
-20.3%
112,536
+6.2%
0.00%
Q4 2016$1,101,000
+0.5%
105,922
+10.6%
0.00%
Q3 2016$1,096,000
+10.8%
95,764
-0.2%
0.00%
Q2 2016$989,000
+55.0%
95,934
+91.0%
0.00%
Q1 2016$638,000
-25.8%
50,217
+0.1%
0.00%
Q4 2015$860,000
+43.6%
50,143
+6.6%
0.00%
Q3 2015$599,00047,0290.00%
Other shareholders
CIDARA THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 1,677,194$819,0001.02%
BVF INC/IL 6,861,127$3,352,0000.16%
5AM Venture Management, LLC 1,134,511$554,0000.14%
Knott David M Jr 635,254$310,0000.13%
Nantahala Capital Management 4,819,090$2,355,0000.12%
West Family Investments, Inc. 368,910$180,0000.07%
Stonepine Capital Management, LLC 208,443$102,0000.05%
JEPPSON WEALTH MANAGEMENT, LLC 181,075$88,0000.04%
Ground Swell Capital, LLC 11,397$6,0000.01%
Point72 Asset Management, L.P. 4,200,000$2,052,0000.01%
View complete list of CIDARA THERAPEUTICS INC shareholders